Can oral contraceptive pills exacerbate migraines, particularly in women with migraine with aura?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Oral Contraceptive Pills Exacerbate Migraines?

Combined hormonal contraceptives are absolutely contraindicated in women with migraine with aura due to significantly increased stroke risk, and they should be avoided in women with migraine without aura who have additional stroke risk factors (age >35 years, smoking, hypertension). 1

The Critical Distinction: Migraine With vs. Without Aura

The relationship between OCPs and migraines centers entirely on aura status, which determines both stroke risk and contraceptive safety:

Migraine With Aura

  • Combined hormonal contraceptives (CHCs) are absolutely contraindicated regardless of menstrual cycle association 1
  • Women with migraine with aura already have 2-4 times increased stroke risk compared to those without migraine 2
  • Adding CHCs multiplies this risk: the combined relative risk reaches 7.02 (95% CI, 1.51-32.68) when migraine with aura, smoking, and OCP use are present 2
  • High migraine frequency (>weekly) in women with aura increases ischemic stroke risk further (HR 4.25,95% CI 1.36-13.29) 2
  • This contraindication applies even to modern low-dose formulations 1, 3

Migraine Without Aura

  • CHCs can be prescribed only if no other arterial risk factors are present 4
  • Additional risk factors that contraindicate CHC use include:
    • Age >35 years
    • Tobacco use
    • Hypertension
    • Diabetes
    • Prior thromboembolic events 5, 4
  • When these factors are absent, modern low-dose CHCs (<50 μg ethinyl estradiol) carry acceptable risk 5, 4

Estrogen Dose Matters Significantly

The 2024 AHA/ASA guidelines emphasize that lower estrogen doses minimize stroke risk 4:

  • Each 10 μg increase in ethinyl estradiol increases stroke risk (OR 1.19,95% CI 1.16-1.23) 4
  • Formulations with <50 μg estrogen have substantially lower risk (RR 2.08) compared to higher doses (RR 4.53, P=0.01) 4
  • Ultra-low-dose continuous formulations (10-15 μg) may even reduce aura frequency 6, 7

Safe Contraceptive Alternatives

For women with migraine with aura or migraine without aura plus risk factors, use progestin-only contraception or non-hormonal methods 4:

Progestin-Only Options (No Increased Stroke Risk):

  • Progestin-only pills (drospirenone or norethindrone)
  • Depo-medroxyprogesterone injection
  • Levonorgestrel IUD
  • Etonogestrel implant 4

Non-Hormonal Options:

  • Copper IUD
  • Barrier methods
  • Surgical sterilization 4

Clinical Decision Algorithm

Step 1: Determine migraine subtype (with or without aura)

Step 2: If migraine with aura:

  • Absolutely contraindicate all CHCs
  • Offer progestin-only or non-hormonal contraception
  • Document contraindication clearly 1, 3, 1

Step 3: If migraine without aura, assess additional risk factors:

  • Age >35 years?
  • Current smoker?
  • Hypertension?
  • Diabetes?
  • Prior thromboembolism?

Step 4: If any additional risk factor present:

  • Avoid CHCs
  • Offer progestin-only or non-hormonal contraception 4

Step 5: If no additional risk factors:

  • CHCs may be used with shared decision-making
  • Prescribe lowest estrogen dose available (≤20 μg ethinyl estradiol preferred)
  • Monitor for development of aura symptoms 4

Critical Pitfalls to Avoid

  1. Failing to distinguish aura status: Many clinicians incorrectly lump all migraines together. Aura is a specific focal neurologic symptom (visual disturbances, sensory changes, speech difficulties) that fundamentally changes contraceptive safety 3

  2. Assuming modern low-dose pills are safe in migraine with aura: Even ultra-low-dose formulations remain contraindicated in migraine with aura 1

  3. Missing new-onset aura: If a woman on CHCs develops aura for the first time, immediately discontinue CHCs 3, 1

  4. Overlooking cumulative risk: The combination of multiple risk factors (migraine with aura + smoking + CHCs) creates exponentially higher stroke risk than any single factor 2

Special Consideration: Menstrual Migraine

Some women with pure menstrual migraine without aura may benefit from continuous CHC use (skipping placebo weeks), as this prevents estrogen withdrawal that triggers attacks 1. However, this applies only when no contraindications exist and requires careful patient selection.

The Bottom Line on Exacerbation

OCPs don't typically "exacerbate" migraine frequency or severity in most women—the primary concern is stroke risk amplification, particularly in those with aura. The 2024 AHA/ASA guidelines make clear that shared decision-making must balance contraceptive efficacy against stroke risk, with progestin-only methods offering equivalent contraceptive protection without the vascular concerns 4.

References

1
Guideline

diagnosis and management of migraine in ten steps.

Nature Reviews Neurology, 2021

3
Guideline

u s. medical eligibility criteria for contraceptive use, 2010.

MMWR Recommendations and Reports, 2010

7
Research

Combined hormonal contraceptives and migraine: An update on the evidence.

Cleveland Clinic journal of medicine, 2017

Related Questions

Can progestin-only oral contraceptives be used in patients with migraine with aura?
Can a combined oral contraceptive (COC) be prescribed for a patient with migraine without aura?
In a patient with migraine with aura, should continuous combined oral contraceptives be avoided and a gonadotropin‑releasing hormone (GnRH) agonist used for endometriosis‑related pain?
Are migraines with aura a contraindication to Depo-Provera (medroxyprogesterone acetate)?
What birth control method is safest for a woman whose migraines worsen with estrogen‑containing contraceptives?
How should amisulpride be dosed when added to clozapine therapy?
In an adult with a sutured wound from a skin excision that cultures positive for Pseudomonas aeruginosa, and who has normal renal function and no fluoroquinolone allergy, what is the recommended antibiotic treatment?
Is a urine protein-to-creatinine ratio of 0.1 normal in a 12-year-old boy, and does it require further evaluation?
What does sickle cell trait indicate about the parents' carrier status?
What is the maximum recommended dose of zaleplon for adults, and how should it be adjusted for elderly patients or those with hepatic impairment?
In a 68-year-old woman with BMI 40, urine creatinine 46.2 mg/dL, urine albumin <0.12 mg/dL, cystatin C 1.2 mg/L (eGFR 55 mL/min/1.73 m²) and serum creatinine 0.93 mg/dL (eGFR 67 mL/min/1.73 m²), what is the appropriate diagnosis and management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.